Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
The use of anticancer drugs to shrink or kill cancerous cells and reduce cancer spreading to other parts of the body.
Retinoids (drugs related to vitamin A) are sometimes used to treat or prevent non-melanoma skin cancer. The retinoids may be taken by mouth or applied to the skin. The use of retinoids is being studied in clinical trials for prevention of squamous cell carcinomas in high risk individuals.
A procedure in which a tumor is scraped off the skin and electrode is used to treat the area with an electric current that stops the bleeding and destroys cancer cells that remain around the edge of the wound.
This treatment is used for superficial skin cancers. The tumor is scraped off the skin with a curette (a sharp, spoon-shaped tool). A needle-shaped electrode is then used to treat the area with an electric current that stops the bleeding and destroys cancer cells that remain around the edge of the wound.
For squamous cell carcinoma treatment, the tumor is removed from the skin and underlying tissue along with standard margin of normal skin. The specimen is sent to the pathology lab to confirm that the margins are clear of cancerous cell.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.